Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study

Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study

Background: The effect of sacubitril/valsartan on survival and hospitalization risk in older patients with heart failure has not been explored. We aimed to investigate the risk of hospitalization and mortality with the use of sacubitril/valsartan vs. enalapril in patients with heart failure.Methods:...

Full description

Bibliographic Details
Main Authors: Swathi Pathadka, Vincent K. C. Yan, Xue Li, Gary Tse, Eric Y. F. Wan, Hayden Lau, Wallis C. Y. Lau, David C. W. Siu, Esther W. Chan, Ian C. K. Wong
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
heart failure
sacubitril/valsartan
enalapril
pharmacoepidemiolgy
mortality
hospitalization
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.602363/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2020.602363/full

Similar Items